Breathomix is a company that provides solutions to diagnose and manage respiratory diseases, including asthma, COPD (chronic obstructive pulmonary disease), and lung cancer. It leverages exhaled breath technologies for the molecular classification of patients with cancer, inflammatory and infectious diseases.